National Key Research and Development Program of China (No. 2016YFD0400505), Natural Science Foundation of Tianjin (No. 17JCYBJC40800), Research Foundation of Tianjin Education Committee (No. 2017ZD03), Startup Fund for “Haihe Young Scholars” of Tianjin University of Science and Technology (No. 1185/10278), Open Fund of Ministry of Education Key Laboratory of Molecular Microbiology and Technology, Nankai University.
Limonene (C10H16) and bisabolene (C15H24) are both naturally occurring terpenes in plants. Depending on the number of C5 units, limonene and bisabolene are recognized as representative monoterpenes and sesquiterpenes, respectively. Limonene and bisabolene are important pharmaceutical and nutraceutical products used in the prevention and treatment of cancer and many other diseases. In addition, they can be used as starting materials to produce a range of commercially valuable products, such as pharmaceuticals, nutraceuticals, cosmetics, and biofuels. The low abundance or yield of limonene and bisabolene in plants renders their isolation from plant sources non-economically viable. Isolation of limonene and bisabolene from plants also suffers from low efficiency and often requires harsh reaction conditions, prolonged reaction times, and expensive equipment cost. Recently, the rapid developments in metabolic engineering of microbes provide a promising alternative route for producing these plant natural products. Therefore, producing limonene and bisabolene by engineering microbial cells into microbial factories is becoming an attractive alternative approach that can overcome the bottlenecks, making it more sustainable, environmentally friendly and economically competitive. Here, we reviewed the status of metabolic engineering of microbes that produce limonene and bisabolene including microbial hosts, key enzymes, metabolic pathways and engineering of limonene/bisabolene biosynthesis. Furthermore, key challenges and future perspectives were discussed.
庞亚如,胡智慧,肖冬光,于爱群. 柠檬烯和红没药烯的微生物代谢工程[J]. Chinese Journal of Biotechnology, 2018, 34(1): 24-33
Copy® 2024 All Rights Reserved